948294-26-6 Usage
General Description
1-bromo-2-fluoro-5-methyl-4-nitrobenzene is a chemical compound with the molecular formula C7H5BrFNO2. It is an aromatic compound that consists of a benzene ring with a bromine atom, a fluorine atom, a methyl group, and a nitro group attached to it. Benzene, 1-bromo-2-fluoro-5-methyl-4-nitro- is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also used as a building block in organic synthesis and as a reagent in chemical reactions. 1-bromo-2-fluoro-5-methyl-4-nitrobenzene is a pale yellow solid with a melting point of 39-41°C and a boiling point of 170-172°C. It is a hazardous chemical and should be handled and stored with caution.
Check Digit Verification of cas no
The CAS Registry Mumber 948294-26-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,8,2,9 and 4 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 948294-26:
(8*9)+(7*4)+(6*8)+(5*2)+(4*9)+(3*4)+(2*2)+(1*6)=216
216 % 10 = 6
So 948294-26-6 is a valid CAS Registry Number.
948294-26-6Relevant articles and documents
INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE
-
Page/Page column 169, (2018/06/30)
Compounds of formula (I') and methods of their use and preparation, as well as compositions comprising compounds of formula (I').
NEW SUBSTITUTED CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS
-
Page/Page column 315; 316, (2017/08/20)
The present invention relates to pharmaceutical agents of formula (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF- KB-inducing kinase (NIK - also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.